JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Un-Audited Financial ....

CIN: L74110HP2004PLC0275 58 To, Date: 05 August,2026 The Listing Department The Listing Department Bombay Stock Exchange Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street Mumbai – 400001 Mumbai – 400051 Scrip Code: 532771 Trading Symbol: JHS Sub: Intimation of Board Meeting – pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir, Pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that meeting of the Board of Directors of the Company will be held on Tuesday, 11th August, 2026, inter alia to consider and approve, the Un-Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, as amended from time to time, the trading window of the Company has been closed from July 01, 2026 and shall remain closed till 48 hours from the announcement of the Un-Audited Financial Results. The above intimation will also be available on the website of the Company at www.svendgaard.com. We request you to kindly take the above information on record. For and on the behalf of, JHS Svendgaard Laboratories Limited Komal Jha Company Secretary and Compliance Officer